A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Malignant Bone Disease. - Related Studies

A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Malignant Bone Disease.

This study is currently recruiting participants.

Study NCT00502736. Last updated on December 2, 2008. Information provided by Hoffmann-La Roche

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Pain;
		Bone Neoplasms;
		Neoplasm Metastasis

2	Additional conditions recognized in this trial
		Bone Neoplasms
		Breast Neoplasms
		Neoplasms

3	More general conditions related to this trial
		Bone Diseases
		Breast Diseases
		Musculoskeletal Diseases
		Neoplasms by Site
		Neoplastic Processes
		Pathologic Processes
		Skin Diseases

4	Interventions listed in this trial
		ibandronate [Bondronat]

5	Additional drug interventions recognized in this trial
		Ibandronic acid

6	More general drug interventions related to this trial
		Bone Density Conservation Agents
		Pharmacologic Actions
		Physiological Effects of Drugs

7	Sponsors listed in this trial
		Hoffmann-La Roche